Hotspots of aberrant enhancer activity in fibrolamellar carcinoma reveal molecular mechanisms of oncogenesis and intrinsic drug resistance
暂无分享,去创建一个
P. Sethupathy | C. Danko | John D. Scott | M. Kanke | Timothy A. Dinh | Rosanna K. Ma | F. Smith | R. Bunaciu | Adam B. Francisco | R. Sritharan | Andrew P. Massa | John D. Scott | Matt Kanke